Overview
Recombinant DNA technologies are widely used for the production of useful metabolites, both for industrial and medical applications. However, the burden caused by the production of an heterologous system can slow down cell growth with lower recovery yields.
My research focuses on examining the causes of physiological burden in E. coli and mammalian cells when transformed with foreign genetic devices in order to understand how to design better synthetic systems for useful purposes.